Uncategorized Archives - Page 92 of 112

WednesdayAug 22, 2018 11:40 am

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Acquires Leading European CBD Company HemPoland

Acquisition includes 100 percent of issued and outstanding shares of privately-held HemPoland in an immediate accretive cash and share transaction worth $15.5 million with an additional $10.3 million committed to R&D, global expansion Agreement opens European gateway with distribution channels to over 750 million people and sales in over 700 locations across 13 countries In 2017, HemPoland produced more than 32,000 kg of organic dried flower and 310 kg of organic CBD oils from over 1,250 acres of cultivation Deal accelerates TGOD’s strategic plan to become the world’s largest organic cannabis brand In a move that dramatically accelerates its strategic…

TuesdayAug 21, 2018 1:56 pm

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Funds Cannabis Companies with Innovative Royalty Financing Model

FinCanna advances $2.25 million to Refined Resin Technologies and ezGreen Compliance California sales account for one-third of U.S. cannabis market California market projected to grow by CAGR of 23 percent to $6.5 billion by 2020 California is now home to the largest legal cannabis market in the world. A pioneer of medical marijuana, which it legalized in 1998, the state has gone a step further by legalizing adult use of marijuana as of January 1, 2018. As a result, sales, already accounting for one-third of legal cannabis sales revenues in the U.S., are projected to reach $4.3 billion in 2018…

MondayAug 20, 2018 2:14 pm

The Green Organic Dutchman Ltd. (TSX: TGOD) (OTC: TGODF) Prepares to Spin Off Acquisitions Entity with Opportunity for Shareholders

The Green Organic Dutchman is building a cannabis industry presence with focus on premium, craft-grown product Company is building 1.38 million square feet of cultivation facilities in Canada, Jamaica New Acquisitions Corporation will focus on monetizing TGOD’s experience in finding worldwide opportunities Enters LOI with Denmark-based Knud Jepsen, increasing funded capacity to 195,000 kg annually Amid the rush to market cannabis products in increasingly varied ways, medical cannabis research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) is preparing to reward its shareholders and boost its bottom line by spinning off a new corporation that…

FridayAug 17, 2018 1:42 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Progress in Revolutionary Alternative to Smoking for Drug Delivery

Smoking-related deaths have reached six million a year worldwide Lexaria’s patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking’s hazards Second round of testing continues to indicate that patented DehydraTECH™ platform provides rapid delivery with high bioavailability As world drug industry regulations undergo revolutionary change and increasingly healthy populations find themselves challenged to meet the cares of old age, Canadian biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is forging a path that establishes it as a pioneer in the field of drug delivery platforms. Lexaria’s mission is to ensure…

ThursdayAug 16, 2018 1:47 pm

PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Medicinal Cannabis Division Targets Treatment Option for Anxiety Disorders

Anxiety is implicated in several chronic physical illnesses including heart disease, respiratory disorders and gastrointestinal conditions Scientific evidence in several studies shows that CBD exhibits anti-inflammatory and anti-anxiety properties Newly created medicinal cannabis division will focus on development of cannabinoids as preventative treatment for anxiety disorders Use of PreveCeutical’s proprietary Sol-gel nasal delivery platform for cannabinoid therapy promises ease of use, sustained release, better efficacy Preventative medicine industry represents a $3.8 trillion market Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is tackling a topic that many people hesitate to bring up – anxiety disorders, including…

MondayAug 13, 2018 12:09 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is Named for its Attention to Preventative Health Care

Private placement of $4.9 million in June 2018 Five R&D programs currently underway Preventative health care market set to reach $200 billion by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is on a mission neatly expressed in its name and in the metaphoric maxim “an ounce of prevention is worth a pound of cure.” Yet, notwithstanding that axiom, medicinal practice and health care have been viewed, for almost a millennium, mainly as “cure,” despite always being administered with a dose of “prevention.” Now, in the 21st century, that auxiliary aspect seems to be gaining the recognition it…

MondayAug 13, 2018 11:36 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study on TurboCBD Capsules Corroborates Earlier DehydraTECH Test Results

Significant bioavailability results were reported from LXRP’s randomized, double-blind European study that evaluated its proprietary TurboCBD capsules, powered by DehydraTECH Results corroborate and confirm in vitro and in vivo studies of DehydraTECH technology that measured high levels of drug delivery being achieved faster than with matching controls LXRP says that it is pleased that DehydraTECH has, to date, repeatedly proved evidence of success within human studies; technology earlier demonstrated ability to deliver nicotine Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is pleased to report significant bioavailability results from its randomized and double-blind European human clinical study of DehydraTECH™ powered TurboCBD™…

MondayAug 13, 2018 10:50 am

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Companies Gain Traction in US Medical Cannabis Space

FinCanna’s royalty finance model could be a game changer for companies needing capital while operating in the U.S. medical cannabis space Pilot marketing program offering HIPAA-compliant point-of-sale solution and inventory tracking system launched in California’s medical cannabis marketplace The U.S. medical cannabis market is projected to grow at 11.8 percent CAGR through 2025 from $5.1 billion to an estimated $12.5 billion in 2025 (New Frontier Data) FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company focused on becoming the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry, continues to gain momentum…

WednesdayAug 08, 2018 12:58 pm

Investment Researchers Peg Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) as Example of ‘Badly Mispriced’ Stock with Return Potential

Beacon Securities Limited argues that Sunniva’s Canadian greenhouse alone is worth more than its entire market cap California facility, Canadian cannabis clinics add to company’s value Sunniva also bolstered by agreement with licensed producer Canopy Growth Corp. amid heightened M&A activity in cannabis sector Cannabis supplier Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) strengthening foothold in California’s and Canada’s consumer-populated markets has been failing to translate to its stock price and market cap since it began trading on the Canadian Securities Exchange and the U.S. OTCQX® Best Market in January, leading investment researchers at Beacon Securities Limited (http://cnw.fm/PhE2A) to classify Sunniva’s public offering as a…

TuesdayAug 07, 2018 11:32 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) Reaches Key Milestones toward Imminent Launch of Seed-to-Sale Cannabis Tracking Software

Major features finalized under aggressive deadline, with product launch mere weeks away Proprietary technology suite tracks cannabis end-to-end with blockchain-protected solution for growers, breeders Current cannabis testing system vulnerable, leaving consumers and producers exposed to risk Strategic partnership announced to implement BLOCKStrain platform’s benefits into regulatory framework for medical and adult-use cannabis in Canada Canada’s inexorable march toward full legalization of cannabis for the adult user in both the medical and recreational markets is much anticipated by the public and Vancouver, Canada-based BLOCKStrain Technology Corp. (TSX.V: DNAX). Major features of BLOCKStrain’s proprietary, end-to-end cannabis tracking platform are rapidly being finalized by…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

Category: Uncategorized